CNS Pharmaceuticals Inc. (CNSP)

AI Score

Unlock

1.09

0.05 (4.81%)

At close: Apr 25, 2025, 3:59 PM

1.06

-2.64%

After-hours: Apr 25, 2025, 05:47 PM EDT

CNS Pharmaceuticals Ratios and Metrics

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018
PE Ratio	-0.18	-6.46	-340.8	-3.92K	-9.13K	-13.16K	-26.88K	-4.83K	-8.67K	-25.52K	-38.28K	-50.72K	-68.81K	-131.84K	-154.18K	-198.43K	-122.18K	-164.09K	-162.2K	-219.39K	-321.35K	-1.33M	-2.18M	-4.44M	-141.69K	-4.86M	-3.65M	-3.03M
PEG Ratio	-0.00	0.06	37.02	115.09	-150.39	-2.99K	448.65	191.21	-274.17	6.22K	-4.36K	1.49K	7.11K	11.88K	-27.83K	11.45K	-3.41K	8.77K	-4.29K	9.92K	-1.25K	-20.88K	-20.91K	45.89K	-42.52	194.87K	216.51K	n/a
PS Ratio	n/a	n/a	n/a	n/a	30.84M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
PB Ratio	0.37	43.21	-803.5	-12.55K	-44.27K	-136.78K	176.14K	27.3K	21.89K	41.59K	47.38K	43.19K	135.24K	221.04K	189.56K	255.1K	105.28K	533.45K	430.92K	293.97K	427.4K	17.4B	9.95M	-5.24M	-6.84M	n/a	-20.41M	107.49M
P/FCF Ratio	-0.42	-21.3	-2.09K	-17.41K	-77.29K	-70.48K	-127.05K	-19.76K	-77.24K	-192.39K	-162.24K	-207.78K	-276.5K	-1.01M	-470.59K	-866.01K	-1.02M	-1.04M	-582.78K	-927.83K	-1.31M	-9.93M	-6.01M	-45.46M	-23.57M	-36.3M	-19.27M	-14.55M
P/OCF Ratio	-0.42	-21.3	-2.09K	-17.41K	-77.35K	-70.52K	-127.05K	-19.76K	-77.24K	-192.55K	-162.38K	-207.78K	-276.68K	-1.01M	-470.59K	-866.98K	-1.02M	-1.04M	-585.24K	-931.03K	-1.31M	-9.93M	-6.09M	-45.46M	-23.57M	-36.3M	-19.27M	-14.55M
OCF/S Ratio	n/a	n/a	n/a	n/a	-398.67	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt / Equity Ratio	0.05	0.01	-0.03	-0.05	-0.07	-0.02	0.07	0.08	0.05	0.00	0.01	0.02	0.06	0.00	0.01	0.03	0.03	n/a	n/a	n/a	n/a	1.39K	0.79	-0.41	-0.58	n/a	-2.03	3.48
Quick Ratio	3.43	1.82	0.32	0.26	0.23	0.51	1.52	1.78	2.55	6.99	12.34	13.78	3.50	4.63	7.58	6.72	8.13	4.93	15.14	18.42	25.38	0.99	1.27	0.35	0.48	n/a	0.75	1.16
Current Ratio	3.43	1.82	0.32	0.26	0.23	0.51	1.52	1.78	2.55	6.99	12.34	13.78	3.50	4.63	7.58	6.72	8.13	4.93	15.14	18.42	25.38	0.99	1.27	0.35	0.48	n/a	0.75	1.16
Asset Turnover	n/a	n/a	n/a	n/a	0.00	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Interest Coverage	-1.15K	-2.49K	-566.47	-535.07	-1.87K	-2.47K	-1.1K	-906.28	-2.38K	-6.36K	-2.21K	-1.08K	-1.25K	-4.03K	-1.62K	-963.35	-919.62	n/a	n/a	n/a	-697.74	-92.46	-24.94	-11.89	-14.93	-7.29	-30.57	n/a
Return on Equity	-0.51	-1.67	0.59	0.80	1.21	2.60	-1.64	-1.41	-0.63	-0.41	-0.31	-0.21	-0.49	-0.42	-0.31	-0.32	-0.22	-0.81	-0.66	-0.33	-0.33	-3.27K	-1.14	0.30	12.07	n/a	1.40	-8.86
Return on Assets	-0.37	-0.76	-1.02	-2.13	-3.16	-1.94	-0.62	-0.67	-0.39	-0.35	-0.29	-0.2	-0.37	-0.33	-0.27	-0.27	-0.19	-0.67	-0.62	-0.32	-0.32	-0.51	-0.26	-0.38	-9.7	n/a	-0.28	-1.24
Return on Invested Capital	-0.49	-1.66	0.61	0.84	1.30	2.68	-1.54	-1.31	-0.64	-0.41	-0.31	-0.18	-0.4	-0.42	-0.3	-0.31	-0.21	-0.81	-0.66	-0.33	-0.33	-2.33	-0.62	0.04	0.90	n/a	-1.06	-1.94
Dividend Yield	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Payout Ratio	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit Margin	n/a	n/a	n/a	n/a	0.85	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Net Profit Margin	n/a	n/a	n/a	n/a	-844.9	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Profit Margin	n/a	n/a	n/a	n/a	-844.9	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Profit Margin	n/a	n/a	n/a	n/a	-845.55	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
FCF Margin	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
EBITDA Margin	n/a	n/a	n/a	n/a	-844.3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a